Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection

Kidney International Reports(2020)10.1016/j.ekir.2020.07.023Source: DataRank Database

Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection is a research paper published in Kidney International Reports (2020). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

gen go

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.16)OA: goldTopics (45)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Swastika Sur ORCID,Tara K. Sigdel ORCID,Mark Nguyen,Elena Crespo ORCID,Alba Torija ORCID

Live enrichment

PubMed:33102963 PMC:PMC7569686 OpenAlex:https://openalex.org/W3045343145

Instituto de Salud Carlos III

Grant: PI13/01263

Instituto de Salud Carlos III

Grant: PI19/01710

European Regional Development Fund

Grant: 1U19AI128913

European Regional Development Fund

Grant: FI17/00233

NIAID NIH HHS

Grant: U19 AI128913

National Institutes of Health

Grant: 5U19AI128913-05

Mapping Immune Responses to CMV in Renal Transplant Recipients

National Institutes of Health

FWCI

2.16

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.kireports.org/article/S2468024920314224/pdf

publisherhttp://www.kireports.org/article/S2468024920314224/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468024920314224?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024920314224?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ekir.2020.07.023

Fields of Study

Renal Transplantation Outcomes and TreatmentsSingle-cell and spatial transcriptomicsHIV Research and Treatment0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

GeneTranscriptomePhenotypeMedicineImmune systemGene expressionBiologyComputational biologyImmunologyGeneticsKidney transplantationsystems biologyRna SequencingAntibody-mediated RejectionT Cell–mediated RejectionKidney DiseaseBiomedical and clinical sciencesNefrología y urologíaRenal and urogenitalTrasplantament renal2404.01 BioestadísticaClinical Research2.1 Biological and endogenous factorsAetiologyTransplantationscreening and diagnosis3205.06 NefrologíaHealth sciencesOrgan TransplantationT cell-mediated rejectionDiseases of the genitourinary system. Urology4.1 Discovery and preclinical testing of markers and technologiesDetectionRebuig (Biologia)Graft rejectionBiomatemáticas519.2:61RC870-923616.61

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.25138007.v1figshare

Additional file 1 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.25138007figshare

Additional file 2 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.25138060.v1figshare

Additional file 2 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.25138060figshare

Additional file 3 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676167.v1figshare

Additional file 3 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676167figshare

Additional file 4 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676170.v1figshare

Additional file 4 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676170figshare

Additional file 5 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676173.v1figshare

Additional file 5 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676173figshare

Additional file 6 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676176.v1figshare

Additional file 6 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676176figshare

Additional file 7 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676179.v1figshare

Additional file 7 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676179figshare

Additional file 8 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676182.v1figshare

Additional file 8 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676182figshare

Additional file 13 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676197figshare

Additional file 14 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676200.v1figshare

Additional file 15 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676203.v1figshare

Additional file 14 of Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes

10.6084/m9.figshare.26676200figshare